The habitual use of Glucosamine supplements might also be related to a lower risk of cardiovascular disease (CVD), a recent research reveals.
Glucosamine, mostly sold in UK pharmacies as a food supplement, is widely used to relieve osteoarthritis and other joint pain.
The report published in the British Medical Journal scrutinised data from 466,039 participants without CVD at baseline and filled up a questionnaire on supplement use, which included glucosamine.
The participants were enrolled from 2006 to 2010 and the researchers followed them up until 2016.
The research declares that glucosamine might have a preventive role in the development of CVD. Habitual glucosamine use was associated with a 10% lower risk of total CVD events and a 9 to 22 per cent lower risk of individual CVD events, such as CVD death, coronary heart disease, and stroke.
However, further clinical trials are needed to test this hypothesis.